Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

China Resources Double-Crane Pharmaceutical Co Ltd to Divest Stake in Subsidiary


Friday, 10 May 2013 08:00pm EDT 

China Resources Double-Crane Pharmaceutical Co Ltd announced that it has decided to transfer its 66.954% stake in a controlling subsidiary, Changsha Double-Crane Medicine Co., Ltd. to China Resources Pharmaceutical Group Limited, for RMB 378,357,054. 

Company Quote